FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of quinazoline of the formula (I) where Y1 means O-, -S-, -NR5-CO where R5 means hydrogen atom; R1 means hydrogen atom or C1-3- alkoxy-group; R2 means hydrogen atom; m means a whole number from 1 to 5; R3 means hydroxy- group, halogen atom, C1-3-alkyl, C1-3-alkoxy-group, C1-3-alkanoylhydroxy-group or cyano-group; R4 means one of five groups that is optionally substituted pyridone, phenyl or aromatic heterocyclic group with 1-3 heteroatoms taken among O, N and S or it comprises such group and their salts. Invention relates also to methods of their synthesis and pharmaceutical compositions containing compound of the formula (I) or its pharmaceutically acceptable salt as active component. Compounds of the formula (I) and their pharmaceutically acceptable salts inhibit effects of VEGF that is useful for treatment of many diseases including cancer and rheumatic arthritis. Invention relates also to method of achievement of anti-angiogenic effect and/or effect of decrease of vascular penetration in warm- blooded animal involving administration to indicated animal the effective amount of compound of the formula (I) or its pharmaceutically acceptable salt. EFFECT: improved method of synthesis, valuable medicinal properties of compounds. 19 cl
Title |
Year |
Author |
Number |
DERIVATIVES OF QUINAZOLINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF, METHOD OF ATTAINMENT OF ANTIANGIOGENIC EFFECT AND/OR EFFECT OF BLOOD VESSEL PERMEABILITY REDUCTION IN WARM-BLOODED ANIMAL |
1997 |
- Tomas Ehndrju Piter
- Ehnneken Loran Fransua Andre
- Dzhonstoun Krejg
- Stouks Ehlejn Sofi Ehlizabet
- Loman Zhan-Zhak Marsel'
- Klehjton Ehdvard
|
RU2198879C2 |
QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF VESSEL ENDOTHELIUM GROWTH FACTOR |
1997 |
- Tomas Ehndrju Peter
- Dzhonstoun Krehjg
- Ehnnekehn Loran Fransua Andre
|
RU2196137C2 |
QUINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND A METHOD FOR REACHING ANTIPROLIFERATIVE EFFECTS |
1996 |
|
RU2153495C2 |
DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID |
1993 |
|
RU2127263C1 |
QUINAZOLINE DERIVATIVES AS INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) |
2000 |
- Ehnneken Loran Fransua Andre
- Stouks Ehlajn Sofi Ehlizabet
- Tomas Ehndrju Piter
|
RU2291868C2 |
DERIVATIVES OF QUINAZOLINE AS INHIBITORS OF ANGIOGENESIS |
2000 |
- Ehnnekehn Loran Fransua Andre
- Ple Patrik
- Stouks Ehlejn Sofi Ehlizabet
- Makkerrecher Darren
|
RU2262935C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
1996 |
|
RU2198878C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
1996 |
|
RU2182574C2 |
DERIVATIVES OF 4-MERCAPTOPYRROLIDINE AS INHIBITORS OF FARNESYLTRANSFERASE |
1996 |
- Bojl Frehnsis Tomas
- Dehvis Dehvid Kh'Ju
- Kenni Piter Vedderben
- Matus'Jak Zbignev Stehnli
- Skoulz Piter Beverli
- Vardluort Dzhejms Majkl
|
RU2191773C2 |
CARBOPENEM DERIVATIVES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND HYDROLYZED IN VIVO ESTERS (VARIANTS), METHOD OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY, DERIVATIVES OF PYRROLIDINE-4-YLTHIOL AND PROTECTED DERIVATIVES OF PYRROLIDINE-4-YLTHIOL |
1993 |
- Majkl Dzhon Betts
- Garet Mors Dehvis
- Majkl Lingard Svejn
|
RU2117659C1 |